In Russia, preclinical trials of a cancer vaccine have been completed. This was announced by Academician of the Russian Academy of Sciences, Andrey Kaprin.
The oncovaccine was created using mRNA technology. The essence of the drug lies in collecting tumor material to analyze its characteristics. Then, a tumor passport is created for further use of the data in personalizing the vaccine.
We have passed the preclinical stage. Now a letter has been sent to the Ministry of Health for permission to conduct the first phase of trials.
As soon as the department gives permission, the trials will continue on volunteers. Specialists will select the participants.
Earlier www1.ru reported that in Russia they created a biocomposite to fight melanoma.
Read materials on the topic:
Russian application for determining skin cancer "ProRodinki" will start working in polyclinics
Cancer defeated?: Russia has developed a revolutionary vaccine against all types of cancer